Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibiotic-induced disruption of the microbiome exacerbates chemotherapy-induced diarrhoea and can be mitigated with autologous faecal microbiota transplantation
Hannah R. Wardill, Stijn A.R. van der Aa, Ana Rita da Silva Ferreira, et al.
European Journal of Cancer (2021) Vol. 153, pp. 27-39
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

From Pathogenesis to Intervention: The Importance of the Microbiome in Oral Mucositis
Júlia S. Bruno, Ghanyah Al-Qadami, Alexa M. G. A. Laheij, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8274-8274
Open Access | Times Cited: 25
Dysbiosis–NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes
Sara Fanijavadi, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 730-730
Open Access | Times Cited: 1
The role of gut microbiota and metabolites in cancer chemotherapy
Shiyu Li, Shuangli Zhu, Jun Yu
Journal of Advanced Research (2023) Vol. 64, pp. 223-235
Open Access | Times Cited: 19
Oral-Gut Microbiome Axis in the Pathogenesis of Cancer Treatment-Induced Oral Mucositis
Ghanyah Al-Qadami, Ysabella Van Sebille, Joanne M. Bowen, et al.
Frontiers in Oral Health (2022) Vol. 3
Open Access | Times Cited: 28
2’-Fucosyllactose Ameliorates Chemotherapy-Induced Intestinal Mucositis by Protecting Intestinal Epithelial Cells Against Apoptosis
Gang Zhao, Jessica N. Williams, M. Kay Washington, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 13, Iss. 2, pp. 441-457
Open Access | Times Cited: 30
Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework
Andrea M. Stringer, Benjamin M. Hargreaves, Rui Amaral Mendes, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 8
Open Access | Times Cited: 4
Is There an Interplay between Environmental Factors, Microbiota Imbalance, and Cancer Chemotherapy-Associated Intestinal Mucositis?
Camila Fernandes, Mahara Coelho Crisostomo Miranda, Cássia Rodrigues Roque, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1020-1020
Open Access | Times Cited: 4
Whey-based diet containing medium chain triglycerides modulates the gut microbiota and protects the intestinal mucosa from chemotherapy while maintaining therapy efficacy
Hannah R. Wardill, Ana Rita da Silva Ferreira, Himanshu Kumar, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 10
Unveiling the Interplay Between the Human Microbiome and Gastric Cancer: A Review of the Complex Relationships and Therapeutic Avenues
Jenan Al‐Matouq, Hawra Al-Ghafli, Noura N. Alibrahim, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 226-226
Open Access
Restore intestinal steady-state: new advances in the clinical management of chemotherapy-associated diarrhea and constipation
Miaoqi Chen, Yamao Li, Peijun Chen
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Open Access
Fecal microbiota transplantation enhanced the effect of chemoimmunotherapy by restoring intestinal microbiota in LLC tumor-bearing mice
Xinmeng Wang, Qian Geng, Hua Jiang, et al.
BMC Immunology (2025) Vol. 26, Iss. 1
Open Access
A Synbiotic Ameliorates Con A‐Induced Autoimmune Hepatitis in Mice through Modulation of Gut Microbiota and Immune Imbalance
Qingqing Liu, Hao Yang, Xing Kang, et al.
Molecular Nutrition & Food Research (2023) Vol. 67, Iss. 7
Closed Access | Times Cited: 9
Targeting the gut microbiota to alleviate chemotherapy-induced toxicity in cancer
Yaning Xu, Haiyan Du, Yu‐Chun Chen, et al.
Critical Reviews in Microbiology (2023) Vol. 50, Iss. 5, pp. 564-580
Closed Access | Times Cited: 8
β-Lactam Dosing in Critical Patients: A Narrative Review of Optimal Efficacy and the Prevention of Resistance and Toxicity
João Gonçalves-Pereira, Joana Fernandes, Ana Rita Duarte, et al.
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1839-1839
Open Access | Times Cited: 13
Mucositis and Infection in Hematology Patients
Nicole M. A. Blijlevens, Charlotte E. M. de Mooij
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9592-9592
Open Access | Times Cited: 7
Modulation of mercaptopurine intestinal toxicity and pharmacokinetics by gut microbiota
Jiamin Xu, Jiaqi Han, Siyao Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116975-116975
Open Access | Times Cited: 2
The Role of the Gut Microbiome in Neuroinflammation and Chemotherapy-Induced Peripheral Neuropathy
Svetlana Shatunova, Rubina Aktar, Madusha Peiris, et al.
European Journal of Pharmacology (2024) Vol. 979, pp. 176818-176818
Open Access | Times Cited: 2
Carbapenem-Resistant Gram-Negative Bacteria-Related Healthcare-Associated Ventriculitis and Meningitis: Antimicrobial Resistance of the Pathogens, Treatment, and Outcome
Yi Ye, Yueyue Kong, Jiawei Ma, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 10
Supporting the gastrointestinal microenvironment during high-dose chemotherapy and stem cell transplantation by inhibiting IL-1 signaling with anakinra
Hannah R. Wardill, Charlotte E. M. de Mooij, Ana Rita da Silva Ferreira, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Potential of Establishing the Corresponding Human Microbial Community in Pseudo Germ-Free Mice through Fecal Microbe Transfer from Three Urolithin Metabotypes
Wenyan Xian, Shiying Yang, Yu Deng, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 30, pp. 9388-9398
Closed Access | Times Cited: 8
Exercise and the gut microbiome: implications for supportive care in cancer
Nicolas H. Hart, Matthew P. Wallen, M. Farley, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 12
Closed Access | Times Cited: 4
Pharmacomicrobiomics in precision cancer therapy: bench to bedside
Khanh Le Ngoc, Tran Thu Ha Pham, Tiep Khac Nguyen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
CDK4/6 inhibitor modulating active and quiescent intestinal stem cells for prevention of chemotherapy‐induced diarrhea
Jinnan Xiang, Haoyu Wang, Qianqian Tao, et al.
The Journal of Pathology (2023) Vol. 260, Iss. 3, pp. 235-247
Closed Access | Times Cited: 3
Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?
Karolina Kaźmierczak-Siedlecka, Nikola Bulman, Paweł Ulasiński, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 3
Intestinal toll-like receptor 4 knockout alters the functional capacity of the gut microbiome following irinotecan treatment
Kate R. Secombe, Elise E. Crame, Janine S. Y. Tam, et al.
Cancer Chemotherapy and Pharmacology (2021) Vol. 89, Iss. 2, pp. 275-281
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top